Novel Substrates of SCF Ubiquitin Ligases in Cell Cycle Control and Cancer
Novel Substrates of SCF Ubiquitin Ligases in Cell Cycle Control and Cancer
批准号:
7382542
负责人:
MICHELE PAGANO
金额:
$20.3万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-04 至 2009-11-30
关键词:
ApoptosisAreaBindingBiology, OtherBortezomibBoxingCDKN1A geneCancer BiologyCell CycleCell Cycle ProgressionCell Cycle RegulationCell ProliferationCell physiologyCellsClassClinicComplexCyclin EDNA RepairDiseaseElementsEnsureEpithelialF-Box ProteinsGrantGusperimusHumanImmune responseIn VitroLigaseMalignant NeoplasmsMass Spectrum AnalysisMediatingNumbersOncogenicOrphanPharmaceutical PreparationsPharmacologic SubstanceProcessProteasome InhibitorProtein OverexpressionProteinsProteolysisProto-OncogenesRNA InterferenceRecruitment ActivityResearchRestRoleSKP Cullin F-Box Protein LigasesScreening procedureSignal Transduction PathwaySpecificitySpeedSystemTestingTherapeuticTimeTissuesTumor Suppressor ProteinsUbiquitinUbiquitin-Conjugating EnzymesUbiquitin-mediated Proteolysis PathwayVariantWorkbaseinhibitor/antagonistinterestmouse modelmulticatalytic endopeptidase complexnoveloncoprotein p21p27 Cell Cycle Proteinp27 Enzyme Inhibitorprotein degradationresponsesmall molecule librariestissue culture
中文摘要
泛素系统是细胞过程的主要调节机制,其中速度,
特殊性和时机是至关重要的。泛素介导的关键底物蛋白降解控制细胞
周期进程,信号转导通路,分化,细胞凋亡,DNA修复和
免疫反应。这一过程是由一台多功能机器介导的,该机器由一个监管机构
泛素靶向组件和效应器蛋白质降解引擎。监管
以泛素为靶标的成分本身由以下组成
一些多聚体元素(例如,SCFubiquitin连接酶复合体)贡献了很大一部分
这一过程所固有的特殊性。在人类中,有68个SCFligase,每个都具有
通过不同的F-盒蛋白亚基,通过直接招募底物来提供特异性
连接酶的其余部分,最终进入泛素结合酶。值得注意的是,只有三个
在68个人SCFubiquitin连接酶中(包含F-box蛋白UTrcp、Fbw7和Skp2,
分别)具有成熟的底物,其中许多参与细胞周期控制。
剩余的65F-box蛋白被认为是“孤儿”,因为它们的底物仍在等待
发现号。
我们最近开发了一种新的免疫纯化策略,可以丰富底物
对F-box蛋白进行质谱分析。我们将系统地识别
具有生物学意义的人孤儿F-盒蛋白底物(特定目标1)。因为我们的
研究兴趣,我们将特别关注那些孤儿F-盒蛋白,我们的初步
结果表明,它参与了细胞周期控制和癌症的发生。在目标2下,我们将验证
目标1中确定的生物学意义最大的底物。
鉴于它们在调节细胞增殖方面的关键作用,SCFligase通常是癌症的靶点-
相关的放松管制和参与致癌转化。因此,所获得的信息
来自拟议的研究将与癌症生物学和其他增殖性疾病直接相关
疾病。
英文摘要
The ubiquitin system is a major regulatory mechanism of cellular processes in which speed,
specificity, and timing are critical. Ubiquitin-mediated proteolysis of key substrates controls cell
cycle progression, signal transduction pathways, differentiation,apoptosis, DNA repair and the
immune response. This process is mediated by a multimericmachine, composed of a regulatory
ubiquitin-targeting component and an effector protein degradation engine. Theregulatory
component, which targets ubiquitin to proteins destined for degradation, is itself composed of
several multimeric elements (e.g., the SCFubiquitin ligase complexes) that contribute much of the
specificity inherent in the process. In humans, there are sixty-eight SCFligases, each characterized
by a different F-boxprotein subunit that provides specificity by directly recruiting the substrate to
the rest of the ligase and,ultimately, to the ubiquitin-conjugating enzyme. Notably, only three out
of 68 human SCFubiquitin ligases (containing the F-box proteins UTrcp, Fbw7 and Skp2,
respectively) have well-established substrates, many of which are involved in cell cycle control.
The remaining 65F-box proteins are considered as "orphan" since their substrates still await
discovery.
We have recently developed a novel immunopurification strategy that enriches for substrates of
F-box proteins followed by mass spectrometry analysis. We will systematicallyidentify
biologically significantsubstrates of human orphan F-boxproteins (Specific Aim 1). Because of our
research interest, we will focus particularly on those orphan F-boxproteins that our preliminary
results suggest to be involved in cell cycle control and cancer. Under Aim 2,we will validate the
biologically most significantsubstrates identifiedunder Aim 1.
Given their critical role in regulating cell proliferation, SCFligases are often the target of cancer-
related deregulation and involved in oncogenic transformation. Therefore,the information gained
from the proposed studies will be of direct relevance to cancer biology and other proliferative
diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of the cell proliferation by CRL ubiquitin ligases
-
批准号:10590637
-
项目类别:
-
资助金额:$33.9万
-
财政年份:2020
-
负责人:MICHELE PAGANO
-
依托单位:
Regulation of the cell proliferation by CRL ubiquitin ligases-diversity supplement
-
批准号:10594747
-
项目类别:
-
资助金额:$5.71万
-
财政年份:2020
-
负责人:MICHELE PAGANO
-
依托单位:
Regulation of the cell proliferation by CRL ubiquitin ligases
-
批准号:10725087
-
项目类别:
-
资助金额:$9.79万
-
财政年份:2020
-
负责人:MICHELE PAGANO
-
依托单位:
Regulation of the cell proliferation by CRL ubiquitin ligases
-
批准号:10379088
-
项目类别:
-
资助金额:$33.9万
-
财政年份:2020
-
负责人:MICHELE PAGANO
-
依托单位:
Regulating centrosome homeostasis through the UPS
-
批准号:9178269
-
项目类别:
-
资助金额:$18.43万
-
财政年份:2016
-
负责人:MICHELE PAGANO
-
依托单位:
F-box proteins: deregulated cell cycle control and proteolysis in cancer
-
批准号:8761279
-
项目类别:
-
资助金额:$22.39万
-
财政年份:2013
-
负责人:MICHELE PAGANO
-
依托单位:
Role of the SCF/FBX011 ubiquitin ligase in the control of cell proliferation
-
批准号:8325492
-
项目类别:
-
资助金额:$5.34万
-
财政年份:2011
-
负责人:MICHELE PAGANO
-
依托单位:
Role of the SCF/Fbxo15 ubiquitin ligase in stem cells and cancer biology
-
批准号:8274655
-
项目类别:
-
资助金额:$18.38万
-
财政年份:2011
-
负责人:MICHELE PAGANO
-
依托单位:
Role of the SCF/Fbxo15 ubiquitin ligase in stem cells and cancer biology
-
批准号:8168513
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2011
-
负责人:MICHELE PAGANO
-
依托单位:
Role of the SCF/FBX011 ubiquitin ligase in the control of cell proliferation
-
批准号:8513435
-
项目类别:
-
资助金额:$5.08万
-
财政年份:2011
-
负责人:MICHELE PAGANO
-
依托单位:
Role of the SCF/FBX011 ubiquitin ligase in the control of cell proliferation
-
批准号:8152909
-
项目类别:
-
资助金额:$6.05万
-
财政年份:2011
-
负责人:MICHELE PAGANO
-
依托单位:
Growth Control
-
批准号:7714188
-
项目类别:
-
资助金额:$1.45万
-
财政年份:2008
-
负责人:MICHELE PAGANO
-
依托单位:
Novel Substrates of SCF Ubiquitin Ligases in Cell Cycle Control and Cancer
-
批准号:7188295
-
项目类别:
-
资助金额:$16.9万
-
财政年份:2006
-
负责人:MICHELE PAGANO
-
依托单位:
EXPRESSION OF CELL CYCLE PROTEINS IN BREAST CANCER
-
批准号:2696380
-
项目类别:
-
资助金额:$24.02万
-
财政年份:1998
-
负责人:MICHELE PAGANO
-
依托单位:
F box Proteins and Deregulated Proteolysis in Cancer
-
批准号:6574895
-
项目类别:
-
资助金额:$3.36万
-
财政年份:1998
-
负责人:MICHELE PAGANO
-
依托单位:
Regulation of the G1 Phase by the Ubiquitin Pathway
-
批准号:6881181
-
项目类别:
-
资助金额:$47.36万
-
财政年份:1998
-
负责人:MICHELE PAGANO
-
依托单位:
Regulation of the cell cycle by SCF and APC/C ubiquitin ligases
-
批准号:8106860
-
项目类别:
-
资助金额:$45.6万
-
财政年份:1998
-
负责人:MICHELE PAGANO
-
依托单位:
Regulation of the cell cycle by SCF and APC/C ubiquitin ligases
-
批准号:7258645
-
项目类别:
-
资助金额:$3.13万
-
财政年份:1998
-
负责人:MICHELE PAGANO
-
依托单位:
F-box proteins: deregulated cell cycle control and proteolysis in cancer
-
批准号:7258343
-
项目类别:
-
资助金额:$45.87万
-
财政年份:1998
-
负责人:MICHELE PAGANO
-
依托单位:
Regulation of the cell cycle by SCF and APC/C ubiquitin ligases
-
批准号:8451514
-
项目类别:
-
资助金额:$44.01万
-
财政年份:1998
-
负责人:MICHELE PAGANO
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: